{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:41:54Z","timestamp":1778694114926,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chong Kun Dang Inc.","award":["0620173860"],"award-info":[{"award-number":["0620173860"]}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amjcard.2020.09.044","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T14:10:26Z","timestamp":1601302226000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Optimal Dose and Type of \u03b2-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention"],"prefix":"10.1016","volume":"137","author":[{"given":"Jiesuck","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0016-0747","authenticated-orcid":false,"given":"Jung-Kyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9078-2231","authenticated-orcid":false,"given":"Jeehoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Ho","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5757-7706","authenticated-orcid":false,"given":"Sung Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay Young","family":"Rhew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Woon","family":"Rha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-6968","authenticated-orcid":false,"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Ill","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6463-9407","authenticated-orcid":false,"given":"Kook-Jin","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doo-Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Ok","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Mo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Woo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-5329","authenticated-orcid":false,"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2020.09.044_bib0001","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0002","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0003","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jacc.2015.07.047","article-title":"Effect of beta-blocker dose on survival after acute myocardial infarction","volume":"66","author":"Goldberger","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0004","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007063","article-title":"Benefit of vasodilating beta-blockers in patients with acute myocardial infarction after percutaneous coronary intervention: nationwide multicenter cohort study","volume":"6","author":"Chung","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0005","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1253\/circj.CJ-14-0633","article-title":"Relationship between beta-blocker and angiotensin-converting enzyme inhibitor dose and clinical outcome following acute myocardial infarction","volume":"79","author":"Grall","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0006","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0140-6736(81)91101-6","article-title":"Effect on mortality of metoprolol in acute myocardial infarction. a double-blind randomised trial","volume":"2","author":"Hjalmarson","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0007","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/01.CIR.68.6.1280","article-title":"Comparativeeffects of propranolol and verapamil alone and in combination on left ventricular function and volumes in patients with chronic exertional angina: a double-blind, placebo-controlled, randomised, crossover study with radionuclide ventriculography","volume":"68","author":"Johnston","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"(CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0009","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":"Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomised trials to clinical practice","volume":"25","author":"Viskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/hrt.2010.207365","article-title":"beta-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure","volume":"97","author":"Ambrosio","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0011","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0002-9149(90)91033-3","article-title":"Double-blind comparison of once daily betaxolol versus propranolol four times daily in stable angina pectoris. Betaxolol Investigators Group","volume":"65","author":"Narahara","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0012","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/0002-9149(88)91155-1","article-title":"Comparison of bevantolol and atenolol in chronic stable angina","volume":"61","author":"Rodrigues","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0013","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2014.05.032","article-title":"Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomised trials","volume":"127","author":"Bangalore","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0014","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12928-012-0137-9","article-title":"beta-Blocker therapy and cardiovascular outcomes in patients who have undergone percutaneous coronary intervention after ST-elevation myocardial infarction","volume":"28","author":"Bao","year":"2013","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.amjcard.2012.10.026","article-title":"Impact of beta blockade therapy on long-term mortality after ST-segment elevation acute myocardial infarction in the percutaneous coronary intervention era","volume":"111","author":"Nakatani","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0016","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.amjcard.2010.06.048","article-title":"Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention","volume":"106","author":"Ozasa","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0017","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.jacc.2003.09.071","article-title":"Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?","volume":"43","author":"Kernis","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0018","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jcin.2013.12.206","article-title":"Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention","volume":"7","author":"Yang","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0019","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/eurheartj\/ehm489","article-title":"Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomised clinical trials","volume":"28","author":"Cucherat","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0020","doi-asserted-by":"crossref","first-page":"43F","DOI":"10.1016\/0002-9149(86)90888-X","article-title":"Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials","volume":"57","author":"Kjekshus","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2016.10.012","article-title":"beta-blocker dosage and outcomes after acute coronary syndrome","volume":"184","author":"Allen","year":"2017","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2020.09.044_bib0022","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/eurheartj\/eht565","article-title":"Central blood pressure: Current evidence and clinical importance","volume":"35","author":"McEniery","year":"2014","journal-title":"Eur Heart J"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920310195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914920310195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:44:05Z","timestamp":1777376645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914920310195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"alternative-id":["S0002914920310195"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.09.044","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal Dose and Type of \u03b2-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2020.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}